Evaluation of IFN-γ serum level in nephropatic type 2 diabetic patients

Pakistan Journal of Biological Sciences

Volumn 12, Issue 9, 2009, Pages 746-749

  Nosratabadi, Reza ^a   Arababadi, M K ^b   Hassanshahi, G ^b   Yaghini, N ^b   Pooladvand, V ^b   Shamsizadeh, Ali ^b   Zarandi, E R ^b   Hakimi, H ^b  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytokine; Diabetes; Nephropathy

Indexed keywords

GAMMA INTERFERON;

ADULT; ARTICLE; BLOOD; DIABETIC NEPHROPATHY; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED;

EID: 67651094224     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2009.746.749     Document Type: Article

References (19)

1. Arababadi, M. K., N. Naghavi, G. Hassanshahi and M. Mahmoodi, 2009. CCR5 D 32 mutation is associated with nephropathies of type 2 diabetes? Ann. Saud. Med. (In Press).
2. Bever, C. T., Jr., H. S. Panitch, H. B. Levy, D. E. McFarlin and K. P. Johnson, 1991. Gamma-interferon induction in patients with chronic progressive MS. Neurology, 41:1124-1127.
3. 4+ T-cells and its clinical implications. Cell Immunol., 254:85-90.
4. Cruz, M., C. Maldonado-Bernal, R. Mondragon-Gonzalez, R. Sanchez-Barrera, N. H. Wacher, G. Carvajal-Sandoval and J. Kumate, 2008. Glycine treatment decreases proinflammatory cytokines and increases interferon-γ in patients with type 2 diabetes. J. Endocrinol. Invest, 31:694-699.
5. Giulietti, A., E. E. Van, L. Overbergh, K. Stoffels, R. Bouillon and C. Mathieu, 2007. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1, 25-Dihydroxyvitamin D (3) works as anti-inflammatory. Diabetes Res. Clin. Pract., 77:47-57.
6. Halminen, M., O. Simell, M. Knip and J. Ilonen, 2001. Cytokine expression in unstimulated PBMC of children with type 1 diabetes and subjects positive for diabetes-associated autoantibodies. Scand J. Immunol., 53:510-510.
7. Hoerbelt, R., C. L. Benjamin, T. Shoji, S. L. Houser, A. Muniappan, R. S. Hasse, L. G. Ledgerwood, J. S. Allan, D. H. Sachs and J. C. Madsen, 2008. The effects of tolerance on allograft damage caused by the innate immune system. Transplantation, 85:314-322.
8. Kukreja, A., G. Cost J. Marker, C. Zhang, Z. Sun, K. Lin-Su, S. Ten, M. Sanz, M. Exley, B. Wilson, S. Porcelli and N. Maclaren, 2002. Multiple immunoregulatory defects in type-1 diabetes. J. Clin. Invest., 109:131-140.
9. Litonjua, A. A., D. Sparrow, L. Guevarra, G. T. O'Connor, S. T. Weiss and D. J. Tollerud, 2003. Serum interferongamma is associated with longitudinal decline in lung function among asthmatic patients: The normative aging study. Ann. Allergy Asthma Immunol., 90:422-428.
10. Nathanson, D. and T. Nystrom, 2008. Hypoglycemic pharmacological treatment of type 2 diabetes: Targeting the endothelium. Mol. Cell Endocrinol., 21:21-21.
11. Ozer, G., Z. Teker, S. Cetiner, M. Yilmaz, A. K. Topaloglu, N. Onenli-Mungan and B. Yuksel, 2003. Serum IL-1, IL-2, TNFalpha and INFgamma levels of patients with type 1 diabetes mellitus and their siblings. J. Pediatr Endocrinol. Metab., 16:203-210.
12. Pickup, J. C., G. D. Chusney, S. M. Thomas and D. Burt, 2000. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci., 67:291-300.
13. Seconi, J., V. Watt and D. S. Ritchie, 2003. Nephrotic syndrome following allogeneic stem cell transplantation associated with increased production of TNF-alpha and interferon-gamma by donor T cells. Bone Marrow. Transplant., 32:447-450.
14. Skopinski, P., E. Rogala, B. Duda-Krol, A. Lipinska and E. Sommer et al., 2005. Increased interleukin-18 content and angiogenic activity of sera from diabetic (Type 2) patients with background retinopathy. J. Diabetes Compilc., 19:335-338.
15. Steyn, N. P., E. V. Lambert and H. Tabana, 2008. Nutrition interventions for the prevention of type 2 diabetes. Proc. Nutr. Soc., 10:1-16.
16. Tsiavou, A., D. Degiannis, E. Hatziagelaki, K. Koniavitou and S. A. Raptis, 2004. Intracellular IFN-gamma production and IL-12 serum levels in latent autoimmune diabetes of adults (LADA) and in type 2 diabetes. J. Interferon. Cytokine Res., 24:381-387.
17. Wong, C. K., A. W. Ho, P. C. Tong, C. Y. Yeung, A. P. Kong, S. W. Lun, J. C. Chan and C. W. Lam, 2007. Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy. Clin. Exp. Immunol., 149:123-131.
18. Xie, H. F., J. Li and W. Shi, 2002. Effect of corticosteroids on the balance of Th cytokines in patients with systemic lupus erythematosus. Hunan Yi Ke Da Xue Xue Bao, 27:533-535.
19. Xu, H., K. Nakayama, S. Ogawa, A. Sugiura, T. Kato, T. Sato, H. Sato and S. Ito, 2005. Elevated plasma concentration of IP-10 in patients with type 2 diabetes mellitus. Nippon Jinzo Gakkai Shi., 47:524-530.